Prostate Cancer Market by Diagnostic Techniques, by Radiation Therapy, by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
- Advertising -
According to the report Prostate Cancer, published by Market Data Forecast, the Global market is projected to reach USD 75.56 billion by 2022, at a CAGR of 9.5% from 2017 to 2022.
The prostate cancer market has a high demand for new and innovative drugs which focus on needs which are unmet such as less toxicity, improved survival time, improved effectiveness, better progression free survival, and lesser cost. Prostate cancer is the spreading of cancer in prostate region, which is a gland present in the male reproductive system.
The cancer cells can reach to other parts of the body, viz.
- Advertising -
the lymph nodes and bones from the prostate. In the later stages of cancer it can lead to symptoms such as blood in the urine, difficulty in urination.
Prostate cancer is mostly diagnosed by biopsy.
Get a comprehensive overview of the Global Prostate Cancer: www.marketdataforecast.com/market-…ncer-market-1616/
Global Prostate Cancer: Drivers & Restraints
Prostate Cancer market in this region is driven by factors such as growing number of new and innovative drugs which are expected to get launched in short-term future and rising old age male among others. Also, technological advancements in researching for new techniques to fight prostate cancer, altering lifestyle, rise in the funding in both public and private sector in the field of drug advancement are some of the key factors boosting the growth of the market.
High price of treatment is constraining the growth of this market.
Get accurate market forecast and analysis on the Global Prostate Cancer. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-…16/request-sample
Global Prostate Cancer: Segmentation
By Diagnostic Techniques
- Digital Rectal Exam (DRE)
- Prostate Specific Antigen Test (PSA)
- Radical Prostatectomy
- Trans Urethral Resection (TUR)
By Radiation Therapy
- External Beam Radiation Therapy
- North America
o United States
o South Korea
- Latin America
o Rest of Latin America
- Middle East & Africa
From simple data collection through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: www.marketdataforecast.com/market-…/customize-report
Global Prostate Cancer: Overview
Factors like growing number of new and innovative drugs and increasing number of old age people are affecting the growth of this market positively. However, other factors such as high price of treatment is restraining the growth of this market.
Globally, North America has the largest market for prostate cancer in the world by share, while Asia Pacific and Latin America regions are expected to register the highest growth rate during the forecast period.
Global Prostate Cancer: Key Players
Some of the major companies dominating Global Prostate Cancer Market are GlaxoSmithKline, Sanofi S.A, Varian Medical Systems, Elekta, AstraZeneca, AbbVie, Theragenics, Novartis, Roche, Bayer, Pfizer, Johnson & Johnson, Abbott Laboratories and Genentech among others.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: